Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Journal of PancreatologyOpen Access

Prognosis analysis and recurrence prediction of patients with radical resection of pancreatic neuroendocrine neoplasms: a nomogram-based study

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJ.J. CaoYHYijie HaoHGHengjun Gao

Discussion

Loading...

Member takes

Overview

Retrospective analysis predicts recurrence risk in resectable pancreatic neuroendocrine neoplasms, highlighting AJCC staging and NLR.

Key Points

  • The established nomogram accurately predicts recurrence risk for patients with resectable pancreatic neuroendocrine neoplasms.
  • Analyzing 180 cases revealed AJCC staging, WHO classification, and neutrophil-to-lymphocyte ratio as significant prognostic factors.
  • Cox regression analysis identified independent indicators for overall and relapse-free survival, enhancing prediction accuracy.
  • AUC of 0.906 indicates the nomogram outperforms traditional staging methods in predicting recurrence.

Cite This Study

Cao et al. (2025) studied this question.

synapsesocial.com/papers/68c192579b7b07f3a0616d40https://doi.org/10.1097/jp9.0000000000000239
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic Nomograms for Patients With <scp>NF</scp>‐Pan‐<scp>NET</scp> After Pancreatectomy: A Retrospective Analysis Based on <scp>SEER</scp> Database2024 · 1 citations
  2. 2A Naples prognostic score-based nomogram enhances perioperative risk stratification for resected pancreatic cancer2026 · 1 citations
  3. 3Defining Biological Borderline Resectable Non-Functioning Pancreatic Neuroendocrine Tumors (NF-PanNETs)2025 · 1 citations
  4. 4Postoperative serum tumor markers-based nomogram predicting early recurrence for patients undergoing radical resections of pancreatic ductal adenocarcinoma2024 · 2 citations
  5. 5Predicting Liver Metastasis in Pancreatic Neuroendocrine Tumor After Surgery: A Population-Based Study2023